Vasopressin

From Psychology Wiki

Community portal · Tasks to do · News · Help

Clinical · Educational · Ind&Org · Other fields · Professional · Transpersonal · World

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Personality | Philosophy | Research Methods | Social | Statistics

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology

---

Arginine vasopressin (AVP), also known as vasopressin, argipressin or antidiuretic hormone (ADH), is a hormone found in most mammals, including humans.^[1]

Vasopressin is a peptide hormone. It is derived from a preprohormone precursor that is synthesized in the hypothalamus, from which it is liberated during transport to the posterior pituitary. Most of it is stored in the posterior part of the pituitary gland to be released into the blood stream; some of it is also released directly into the brain.

Contents 1 Physiology 1.1 Function 1.1.1 Kidney 1.1.2 Cardiovascular system 1.1.3 Central nervous system (CNS) 1.2 Control 1.3 Secretion 1.4 Summary Table 2 Structure and relation to oxytocin 3 Role in disease 4 Pharmacology 4.1 Vasopressin analogues 4.2 Vasopressin receptor inhibition 5 See also 6 References 7 Further Reading

[edit] Physiology

[edit] Function

One of the most important roles of AVP is to regulate the body's retention of water, being released when the body is dehydrated; it causes the kidneys to conserve water (but not salt), concentrating the urine, and reducing urine volume. It also raises blood pressure by inducing moderate vasoconstriction. In addition, it has a variety of neurological effects on the brain, having been found, for example, to influence pair-bonding in voles.

A very similar substance, lysine vasopressin (LVP) or lypressin, has the same function in pigs and is often used in human therapy.

[edit] Kidney

AVP increases the permeability to water of the distal convoluted tubules and collecting tubules in the nephrons of kidneys and thus allows water reabsorption and excretion of a smaller volume of concentrated urine - antidiuresis. This occurs through insertion of additional water channels (aquaporins) into the apical membrane of the duct epithelial cells. V2 receptors, G protein-coupled receptors coupled to G_s, on the basolateral membrane of the cells lining the distal convoluted tubules and conducting tubules (in the nephron) have an active site for AVP. The G protein, which is in contact with the V2 receptor inside the cell, dephosphorylates GTP (guanine triphosphate) turning it into GDP (guanine diphosphate) plus an inorganic phosphate ion (Pi). The G protein uses the energy obtained from GTP to move to adenylyl cyclase, triggering adenylyl cyclase to turn ATP (adenine triphosphate)into cAMP (cyclic adenosine monophosphate) plus 2 inorganic phosphates. The repressor protein that regulates the gene for protein kinase A has a binding site for cAMP, causing the repressor protein to change its shape and leave the operator region of the gene. This allows for transcription of the gene for protein kinase A. The gene is then translated to produce protein kinase A. Protein kinase A signals ATP to dephosphorylate, providing energy for vescicles (which have aquaporin channel proteins as a part of their membranes) to move to the apical membrane of the cell and fuse with it. The aquaporin channel proteins allow water to pass out of the nephron (at the distal convoluted tubules and the conducting tubules) and into the cell, increasing the amount of water re-absorbed from the filtrate in the nephron.

AVP also increases permeability of the medullary portion of the collecting duct to urea, allowing increased reabsorption of urea into the medullary interstitium, down the concentration gradient created from the removal of water in the cortical collecting duct.

[edit] Cardiovascular system

Vasopressin, as the name tells, increases the resistance of the peripheral vessels and thus increases arterial blood pressure. This effect appears small in healthy individuals; however it becomes an important compensatory mechanism for restoring blood pressure in hypovolemic shock such as occurs during hemorrhage.

Vasopressin constricts arterioles leading to increased peripheral vascular resistance. However, under normal physiological conditions, there is no net change in blood pressure due to baroreflex activation.

[edit] Central nervous system (CNS)

Vasopressin released within the brain has many actions:

• It has been implicated in memory formation, including delayed reflexes, image, short- and long-term memory, though the mechanism remains unknown, and these findings are controversial. However, the synthetic vasopressin analogue desmopressin has come to interest as a likely nootropic.

• Vasopressin is released into the brain in a circadian rhythm by neurons of the suprachiasmatic nucleus of the hypothalamus.

• Vasopressin released from centrally-projecting hypothalamic neurons is involved in aggression, blood pressure regulation and temperature regulation.

In recent years there has been particular interest in the role of vasopressin in social behavior. It is thought that vasopressin, released into the brain during sexual activity, initiates and sustains patterns of activity that support the pair-bond between the sexual partners; in particular, vasopressin seems to induce the male to become aggressive towards other males.

Evidence for this comes from experimental studies in several species, which indicate that the precise distribution of vasopressin and vasopressin receptors in the brain is associated with species-typical patterns of social behavior. In particular, there are consistent differences between monogamous species and promiscuous species in the distribution of vasopressin receptors, and sometimes in the distribution of vasopressin-containing axons, even when closely-related species are compared. Moreover, studies involving either injecting vasopressin agonists into the brain, or blocking the actions of vasopressin, support the hypothesis that vasopressin is involved in aggression towards other males. There is also evidence that differences in the vasopressin receptor gene between individual members of a species might be predictive of differences in social behavior.

[edit] Control

Vasopressin is secreted from the posterior pituitary gland in response to reductions in plasma volume and in response to increases in the plasma osmolality:

• Secretion in response to reduced plasma volume is activated by pressure receptors in the veins, atria, and carotids.
• Secretion in response to increases in plasma osmotic pressure is mediated by osmoreceptors in the hypothalamus.

The neurons that make vasopressin, in the supraoptic nucleus and paraventricular nucleus, are themselves osmoreceptors, but they also receive synaptic input from other osmoreceptors located in regions adjacent to the anterior wall of the third ventricle. These regions include the organum vasculosum of the lamina terminalis and the subfornical organ.

Many factors influence the secretion of vasopressin:

• Ethanol reduces vasopressin secretion. The resulting decrease in water reabsorption by the kidneys leads to a higher urine output.
• Angiotensin II may stimulate the secretion of vasopressin.^[2]

[edit] Secretion

The main stimulus for secretion of vasopressin is increased osmolarity of plasma. Reduced volume of extracellular fluid also has this effect, but is a less sensitive mechanism.

The vasopressin that is measured in peripheral blood is almost all derived from secretion from the posterior pituitary gland (except in cases of vasopressin-secreting tumours). However there are two other sources of vasopressin with important local effects:

• Vasopressin is produced in the supraoptic nucleus of the hypothalamus and travels down the axons in neurosecretory granules through the infundibulum. These carry the peptide directly to the posterior pituitary gland, where it is stored in Herring bodies until it is released into the blood.
• Vasopressin is also released into the brain by several different populations of neurons (see below).

[edit] Summary Table

Here is a table summarizing some of the actions of AVP at its three receptors, differently expressed in different tissues and exerting different actions:

Type	Second messenger system	Locations	Actions
AVPR1A	phosphatidylinositol/calcium	liver, kidney, peripheral vasculature, brain	vasoconstriction, gluconeogenesis, platelet aggregation, and release of factor VIII and von Willebrand factor; social recognition,[3] circadian tau[4]
AVPR1B	phosphatidylinositol/calcium	pituitary gland, brain	adrenocorticotropic hormone secretion in response to stress;[5] social interpretation of olfactory cues[6]
AVPR2	adenylate cyclase/cAMP	basolateral membrane of the cells lining the collecting ducts of the kidneys (especially the cortical and outer medullary collecting ducts)	insertion of aquaporin-2 (AQP2) channels (water channels). This allows water to be reabsorbed down an osmotic gradient, and so the urine is more concentrated. Release of von Willebrand factor and surface expression of P-selectin through exocytosis of Weibel-Palade bodies from endothelial cells[7][8]

[edit] Structure and relation to oxytocin

The vasopressins are peptides consisting of nine amino acids (nonapeptides). (NB: the value in the table above of 164 amino acids is that obtained before the hormone is activated by cleavage). The amino acid sequence of arginine vasopressin is Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly, with the cysteine residues forming a sulfur bridge. Lysine vasopressin has a lysine in place of the arginine.

The structure of oxytocin is very similar to that of the vasopressins: it is also a nonapeptide with a sulfur bridge and its amino acid sequence differs at only two positions (see table below). The two genes are located on the same chromosome separated by a relatively small distance of less than 15,000 bases in various species. The magnocellular neurons that make vasopressin are adjacent to magnocellular neurons that make oxytocin, and are similar in many respects. The similarity of the two peptides can cause some cross-reactions: oxytocin has a slight antidiuretic function, and high levels of vasopressin can cause uterine contractions.

Here is a table showing the superfamily of vasopressin and oxytocin neuropeptides:

Vertebrate Vasopressin Family
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2	Argipressin (AVP, ADH)	Most mammals
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2	Lypressin (LVP)	Pigs, hippos, warthogs, some marsupials
Cys-Phe-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2	Phenypressin	Some marsupials
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2	Vasotocin†	Non-mammals
Vertebrate Oxytocin Family
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2	Oxytocin (OXT)	Most mammals, ratfish
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Ile-Gly-NH2	Mesotocin	Most marsupials, all birds, reptiles, amphibians, lungfishes
Cys-Tyr-Ile-Gln-Ser-Cys-Pro-Ile-Gly-NH2	Seritocin	Frogs
Cys-Tyr-Ile-Ser-Asn-Cys-Pro-Ile-Gly-NH2	Isotocin	Bony fishes
Cys-Tyr-Ile-Ser-Asn-Cys-Pro-Gln-Gly-NH2	Glumitocin	Skates
Cys-Tyr-Ile-Asn/Gln-Asn-Cys-Pro-Leu/Val-Gly-NH2	Various tocins	Sharks
Invertebrate VP/OT Superfamily
Cys-Leu-Ile-Thr-Asn-Cys-Pro-Arg-Gly-NH2	Diuretic Hormone	Locust
Cys-Phe-Val-Arg-Asn-Cys-Pro-Thr-Gly-NH2	Annetocin	Earthworm
Cys-Phe-Ile-Arg-Asn-Cys-Pro-Lys-Gly-NH2	Lys-Connopressin	Geography & imperial cone snail, pond snail, sea hare, leech
Cys-Ile-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2	Arg-Connopressin	Striped cone snail
Cys-Tyr-Phe-Arg-Asn-Cys-Pro-Ile-Gly-NH2	Cephalotocin	Octopus
Cys-Phe-Trp-Thr-Ser-Cys-Pro-Ile-Gly-NH2	Octopressin	Octopus
†Vasotocin is the evolutionary progenitor of all the vertebrate neurohypophysial hormones. Only vasotocin found in hagfish & lampreys (Agnatha appeared 500 million years ago)

[edit] Role in disease

Decreased vasopressin release or decreased renal sensitivity to vasopressin leads to diabetes insipidus, a condition featuring hypernatremia (increased blood sodium content), polyuria (excess urine production), and polydipsia (thirst).

High levels of vasopressin secretion (syndrome of inappropriate antidiuretic hormone, SIADH) and resultant hyponatremia (low blood sodium levels) occurs in brain diseases and conditions of the lungs. In the perioperative period, the effects of surgical stress and some commonly used medications (e.g., opiates, syntocinon, anti-emetics) lead to a similar state of excess vasopressin secretion. This may cause mild hyponatremia for several days.

[edit] Pharmacology

[edit] Vasopressin analogues

Vasopressin agonists are used therapeutically in various conditions, and its long-acting synthetic analogue desmopressin is used in conditions featuring low vasopressin secretion, as well as for control of bleeding (in some forms of von Willebrand disease) and in extreme cases of bedwetting by children. Terlipressin and related analogues are used as vasocontrictors in certain conditions. Use of vasopressin analogues for esophageal varices commenced in 1970.^[9]

Vasopressin infusion has been used as a second line of management in septic shock patients not responding to high dose of inotropes (e.g., dopamine or norepinephrine). It had been shown to be more effective than epinephrine in asystolic cardiac arrest.^[10] While not all studies are in agreement, a 2006 study of out-of hospital cardiac arrests has added to the evidence for the superiority of vasopressin in this situation.^[11]

[edit] Vasopressin receptor inhibition

Demeclocycline, a tetracycline antibiotic, is sometimes used to block the action of vasopressin in the kidney in hyponatremia due to inappropriately high secretion of vasopressin (SIADH, see above), when fluid restriction has failed. A new class of medication (conivaptan, tolvaptan, relcovaptan, lixivaptan) acts by inhibiting the action of vasopressin on its receptors (V1 and V2), with conivaptan acting on V1a and V2 and the remainder mainly on V2 receptors. The same class of drugs is also being studied in congestive heart failure.

[edit] See also

• Vasoconstrictor drugs

[edit] References

[edit] Further Reading

• Brenner & Rector's The Kidney, 7th ed., Saunders, 2004. Full Text with MDConsult subscription
• Caldwell, H.K. and Young, W.S., III. Oxytocin and Vasopressin: Genetics and Behavioral Implications in Lim, R. (ed.) Handbook of Neurochemistry and Molecular Neurobiology, 3rd edition, Springer, New York, pp. 573-607, 2006. 320kb PDF
• Aarde, S. M., & Jentsch, J. D. (2006). Haploinsufficiency of the arginine-vasopressin gene is associated with poor spatial working memory performance in rats: Hormones and Behavior Vol 49(4) Apr 2006, 501-508.
• Abelson, J. L., Le Melledo, J.-M., & Bichet, D. G. (2001). Dose response of arginine vasopressin to the CCK-B agonist pentagastrin: Neuropsychopharmacology Vol 24(2) Feb 2001, 161-169.
• Aguilera, G., Kiss, A., Liu, Y., & Kamitakahara, A. (2007). Negative regulation of corticotropin releasing factor expression and limitation of stress response: Stress: The International Journal on the Biology of Stress Vol 10(2) Jun 2007, 153-161.
• Akimov, G. A., Golovkin, V. I., Bakharev, V. D., & Yunusova, L. G. (1988). Pathogenesis of treatment of migraines (neuroendocrinological aspect): Soviet Neurology & Psychiatry Vol 21(3) Fal 1988, 65-71.
• Akner, G., Ljunggren, J. G., Kjellman, B. F., Unden, F., & et al. (1988). Adrenocorticotropin and cortisol response to lysine vasopressin in relation to the outcome of the dexamethasone suppression test in major depressive disorder: Acta Psychiatrica Scandinavica Vol 77(4) Apr 1988, 404-410.
• Albeck, D. S. (1992). Peptidergic transmission in the mammalian brain: Dissertation Abstracts International.
• Albeck, D. S., McKittrick, C. R., Blanchard, D. C., Blanchard, R. J., & et al. (1997). Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain: Journal of Neuroscience Vol 17(12) Jun 1997, 4895-4903.
• Albers, H. E., & Cooper, T. T. (1995). Effects of testosterone on the behavioral response to arginine vasopressin microinjected into the central gray and septum: Peptides Vol 16(2) 1995, 269-273.
• Albers, H. E., Dean, A., Karom, M. C., Smith, D., & Huhman, K. L. (2006). Role of V1a vasopressin receptors in the control of aggression in Syrian hamsters: Brain Research Vol 1073-1074 Feb 2006, 425-430.
• Albers, H. E., & Ferris, C. F. (1986). Role of the flank gland in vasopressin induced scent marking behavior in the hamster: Brain Research Bulletin Vol 17(3) Sep 1986, 387-389.
• Albers, H. E., Hennessey, A. C., & Whitman, D. C. (1992). Vasopressin and the regulation of hamster social behavior. New York, NY: New York Academy of Sciences.
• Albers, H. E., Karom, M., & Whitman, D. C. (1996). Ovarian hormones alter the behavioral response of the medial preoptic anterior hypothalamus to arginine-vasopressin: Peptides Vol 17(8) 1996, 1359-1364.
• Albers, H. E., Liou, S. Y., & Ferris, C. F. (1988). Testosterone alters the behavioral response of the medial preoptic-anterior hypothalamus to microinjection of arginine vasopressin in the hamster: Brain Research Vol 456(2) Jul 1988, 382-386.
• Albers, H. E., & Rawls, S. (1989). Coordination of hamster lordosis and flank marking behavior: Role of arginine vasopressin within the medial preoptic-anterior hypothalamus: Brain Research Bulletin Vol 23(1-2) Jul-Aug 1989, 105-109.
• Albert, S. G., Nakra, B. R., Grossberg, G. T., & Caminal, E. R. (1989). Vasopressin response to dehydration in Alzheimer's disease: Journal of the American Geriatrics Society Vol 37(9) Sep 1989, 843-847.
• Albert, S. G., Nakra, B. R. S., Grossberg, G. T., & Caminal, E. R. (1994). Drinking behavior and vasopressin responses to hyperosmolality in Alzheimer's disease: International Psychogeriatrics Vol 6(1) Spr 1994, 79-86.
• Alescio-Lautier, B., Devigne, C., & Soumireu-Mourat, B. (1987). Hippocampal lesions block behavioral effects of central but not of peripheral pre-test injection of arginine vasopressin in an appetitive learning task: Behavioural Brain Research Vol 26(2-3) Nov-Dec 1987, 159-169.
• Alescio-Lautier, B., Metzger, D., Devigne, C., & Soumireu-Mourat, B. (1989). Microinjection of anti-vasopressin serum into hippocampus in mice: Effects on appetitively reinforced task after intraventricular administration of Arg-vasopressin: Brain Research Vol 500(1-2) Oct 1989, 287-294.
• Alescio-Lautier, B., & Soumireu-Mourat, B. (1990). Effects of peripherally administered arginine-vasopressin on learning, retention and forgetting in mice: Behavioural Brain Research Vol 41(2) Dec 1990, 117-128.
• Alexander, S. L., & Irvine, C. H. G. (2002). The Effect of Endotoxin Administration on the Secretory Dynamics of Oxytocin in Follicular Phase Mares: Relationship to Stress Axis Hormones: Journal of Neuroendocrinology Vol 14(7) Jul 2002, 540-548.
• Alexinsky, T., & Alliot, J. (1987). Vasopressin injections impair working memory in a delayed matching to sample task in rats: Behavioral & Neural Biology Vol 48(2) Sep 1987, 167-182.
• Alliot, J. (1990). Effects of vasopressin on spontaneous black-white choices in a T-maze: Pharmacology, Biochemistry and Behavior Vol 35(4) Apr 1990, 981-987.
• Alliot, J., & Alexinsky, T. (1983). Repeated post trial administration of vasopressin impairs subsequent differential reinforcement of low rates (DRL) performance: Behavioural Processes Vol 8(4) Oct 1983, 345-362.
• Alliot, J., & Alexinsky, T. (1991). Food-restriction interacts with vasopressin modulation of activity: Physiology & Behavior Vol 50(1) Jul 1991, 213-220.
• Alliot-Ferrand, J., & Alexinsky, T. (1982). Effects of posttrial vasopressin injections on appetitively motivated learning in rats: Physiology & Behavior Vol 28(3) Mar 1982, 525-530.
• Allon, M. (1991). "Cigarette use and hyponatremia in schizophrenic patients": Reply: American Journal of Psychiatry Vol 148(5) May 1991, 689.
• Al-Shamma, H. A., & de Vries, G. J. (1991). Fiber outgrowth from fetal vasopressin neurons of the suprachiasmatic nucleus, bed nucleus of the stria terminalis, and medial amygdaloid nucleus transplanted into adult Brattleboro rats: Developmental Brain Research Vol 64(1-2) Dec 1991, 200-204.
• Altemus, M., Cizza, G., & Gold, P. W. (1992). Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro: Brain Research Vol 593(2) Oct 1992, 311-313.
• Altemus, M., Pigott, T., Kalogeras, K. T., Demitrack, M., & et al. (1992). Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder: Archives of General Psychiatry Vol 49(1) Jan 1992, 9-20.
• Amico, J. A., Vollmer, R. R., Karam, J. R., Lee, P. R., Li, X., Koenig, J. I., et al. (2004). Centrally administered oxytocin elicits exaggerated grooming in oxytocin null mice: Pharmacology, Biochemistry and Behavior Vol 78(2) Jun 2004, 333-339.
• Anderson, L. T., David, R., Bonnet, K., & Dancis, J. (1979). Passive avoidance learning in Lesch-Nyhan disease: Effect of 1-desamino-8-arginine-vasopressin: Life Sciences Vol 24(10) Mar 1979, 905-910.
• Andrianov, V. V. (1983). The role of neuropeptides and blockers of protein synthesis in neuronal mechanisms of food-getting behavior: Neuroscience and Behavioral Physiology Vol 13(6) Nov-Dec 1983, 442-447.
• Aoki, M., Asai, M., Nishihori, T., Mizuta, K., Ito, Y., & Ando, K. (2007). The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack: Journal of Neuroendocrinology Vol 19(11) Nov 2007, 901-906.
• Appenrodt, E., Juszczak, M., & Schwarzberg, H. (2002). Septal vasopressin induced preservation of social recognition in rats was abolished by pinealectomy: Behavioural Brain Research Vol 134(1-2) Aug 2002, 67-73.
• Appenrodt, E., Schnabel, R., & Schwarzberg, H. (1998). Vasopressin administration modulates anxiety-related behavior in rats: Physiology & Behavior Vol 64(4) Jun 1998, 543-547.
• Appenrodt, E., & Schwarzberg, H. (1999). Septal vasopressin modulates motility and passive avoidance in pinealectomized rats: Physiology & Behavior Vol 66(5) Jul 1999, 757-761.
• Appenrodt, E., & Schwarzberg, H. (2000). Central vasopressin administration failed to influence anxiety behavior after pinealectomy in rats: Physiology & Behavior Vol 68(5) Mar 2000, 735-739.
• Appenrodt, E., & Schwarzberg, H. (2003). Methylphenidate-induced motor activity in rats: Modulation by melatonin and vasopressin: Pharmacology, Biochemistry and Behavior Vol 75(1) Apr 2003, 67-73.
• Appenrodt, E., & Schwarzberg, H. (2003). Pinealectomy blocks modulation of active avoidance by central vasopressin application in rats: Peptides Vol 24(1) Jan 2003, 129-136.
• Aravich, P. F., Rieg, T. S., Ahmed, I., & Lauterio, T. J. (1993). Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: Relationship to anorexia nervosa: Brain Research Vol 612(1-2) May 1993, 180-189.
• Askew, A., Gonzalez, F. A., Stahl, J. M., & Karom, M. C. (2006). Food competition and social experience effects on V-sub(1a) receptor binding in the forebrain of male Long-Evans hooded rats: Hormones and Behavior Vol 49(3) Mar 2006, 328-336.
• Aubock, J., & Konzett, H. (1983). Ischaemic pain versus mental task: Effect on plasma arginine vasopressin in man: Pain Vol 15(1) Jan 1983, 93-99.
• Aubry, J. M., Bartanusz, V., Jezova, D., Belin, D., & Kiss, J. Z. (1999). Single Stress Induces Long-Lasting Elevations in Vasopressin mRNA Levels in CRF Hypophysiotrophic Neurones, but Repeated Stress is Required to Modify AVP Immunoreactivity: Journal of Neuroendocrinology Vol 11(5) May 1999, 377-384.
• Auger, C. J., & De Vries, G. J. (2002). Progestin Receptor Immunoreactivity within Steroid-Responsive Vasopressin-lmmunoreactive Cells in the Male and Female Rat Brain: Journal of Neuroendocrinology Vol 14(7) Jul 2002, 561-567.
• Axelson, J. F., Smith, M., & Duarte, M. (1999). Prenatal flutamide treatment eliminates the adult male rat's dependency upon vasopressin when forming social-olfactory memories: Hormones and Behavior Vol 36(2) Oct 1999, 109-118.
• Babicky, A., Krecek, J., Dlouha, H., & Zicha, J. (1986). Endogenous vasopressin and the weaning period in Brattleboro rats: Physiology & Behavior Vol 36(4) 1986, 631-635.
• Bacharev, V. D., Starikov, V. A., Papsuevich, O. S., & Chipens, G. I. (1983). Effect of activity level of serotoninergic, dopaminergic, and noradrenergic brain systems on the action of arginin-vasopressin neuromodulator of memory: Zhurnal Vysshei Nervnoi Deyatel'nosti Vol 33(1) 1983, 79-87.
• Bachner-Melman, R., Zohar, A. H., Bacon-Shnoor, N., Elizur, Y., Nemanov, L., Gritsenko, I., et al. (2005). Link Between Vasopressin Receptor AVPR1A Promoter Region Microsatellites and Measures of Social Behavior in Humans: Journal of Individual Differences Vol 26(1) 2005, 2-10.
• Bachner-Melman, R., Zohar, A. H., Elizur, Y., Nemanov, L., Gritsenko, I., Konis, D., et al. (2004). Association between a Vasopressin Receptor AVPR1A Promoter Region Microsatellite and Eating Behavior Measured by a Self-Report Questionnaire (Eating Attitudes Test) in a Family-Based Study of a Nonclinical Population: International Journal of Eating Disorders Vol 36(4) Dec 2004, 451-460.
• Baertschi, A. J., & et al. (1984). No role of vasopressin in stress-induced ACTH secretion? : Nature Vol 308(5954) Mar 1984, 85-86.
• Bailey, W. H. (1975). Avoidance behavior in rats with hereditary hypothalamic diabetes insipidus: Dissertation Abstracts International.
• Bailey, W. H., & Weiss, J. M. (1978). Effect of ACTH-sub(4-20 ) passive avoidance of rats lacking vasopressin (Brattleboro strain): Hormones and Behavior Vol 10(1) Feb 1978, 22-29.
• Bakharev, V. D. (1981). Investigation of memory during adaptation to high mountain conditions: Human Physiology Vol 7(6) Nov-Dec 1981, 409-414.
• Bakharev, V. D., & et al. (1984). Effect of arginine-vasopressin neuropeptide on human tolerance of a hot dry environment: Human Physiology Vol 9(5) Jul 1984, 361-368.
• Bakharev, V. D., & et al. (1984). Effect of vasopressin neuropeptides of ACTH fragments on the human cardiovascular and respiratory systems at rest and during exercise: Human Physiology Vol 9(4) May 1984, 288-293.
• Bakharev, V. D., Tilkhomirov, S. M., Papsuevich, O. S., & Chipens, G. I. (1984). The use of vasopressin in the therapy of patients with paranoid schizophrenia: Zhurnal Nevropatologii i Psikhiatrii imeni S S Korsakova Vol 84(1) 1984, 88-92.
• Balaban, C. D., & Severs, W. B. (1991). Toxic effects of somatostatin in the cerebellum and vestibular nuclei: Multiple sites of action: Neuroscience Research Vol 12(1) Oct 1991, 140-150.
• Bales, K. L., & Carter, C. S. (2007). Neuropeptides and the development of social behaviors: Implications for adolescent psychopathology. New York, NY: Oxford University Press.
• Bales, K. L., Kim, A. J., Lewis-Reese, A. D., & Carter, C. S. (2004). Both oxytocin and vasopressin may influence alloparental behavior in male prairie voles: Hormones and Behavior Vol 45(5) May 2004, 354-361.
• Baltissen, R., Teppe, M., Boucsein, W., Fehm-Wolfsdorf, G., & et al. (1991). Effects of vasopressin on the habituation of the orienting reaction in men: Peptides Vol 12(6) Nov-Dec 1991, 1393-1398.
• Bamshad, M., Cooper, T. T., Karom, M., & Albers, H. E. (1996). Glutamate and vasopressin interact to control scent marking in Syrian hamsters (Mesocricetus auratus): Brain Research Vol 731(1-2) Aug 1996, 213-216.
• Bamshad, M., Karom, M., Pallier, P., & Albers, H. E. (1997). Role of the central amygdala in social communication in Syrian hamsters ( Mesocricetus auratus): Brain Research Vol 744(1) Jan 1997, 15-22.
• Bamshad, M., Novak, M. A., & de Vries, G. J. (1994). Cohabitation alters vasopressin innervation and paternal behavior in prairie voles (Microtus ochrogaster): Physiology & Behavior Vol 56(4) Oct 1994, 751-758.
• Bamshad-Alavi, M. (1993). Changes in vasopressin pathways in extrahypothalamic brain regions of male prairie voles (Microtus ochrogaster) during the reproductive period: Dissertation Abstracts International.
• Banet, M., & Wieland, U.-E. (1985). The effect of intraseptally applied vasopressin on thermoregulation in the rat: Brain Research Bulletin Vol 14(2) Feb 1985, 113-116.
• Baratti, C. M., Faiman, C. P., & de Erausquin, G. A. (1989). Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist: Behavioral & Neural Biology Vol 51(3) May 1989, 424-435.
• Bartus, R. T., Dean, R. L., & Beer, B. (1982). Neuropeptide effects on memory in aged monkeys: Neurobiology of Aging Vol 3(1) Spr 1982, 61-68.
• Beckmann, H., Lang, R. E., & Gattaz, W. F. (1985). Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls: Psychoneuroendocrinology Vol 10(2) 1985, 187-191.
• Beckwith, B. E., Couk, D. I., & Till, T. S. (1983). Vasopressin analog influences the performance of males on a reaction time task: Peptides Vol 4(5) Sep-Oct 1983, 707-709.
• Beckwith, B. E., & et al. (1982). Vasopressin analog (DDAVP) facilitates concept learning in human males: Peptides Vol 3(4) Jul-Aug 1982, 627-630.
• Beckwith, B. E., Petros, T. V., Bergloff, P. J., & Staebler, R. J. (1987). Vasopressin analogue ({ddavp}) facilitates recall of narrative prose: Behavioral Neuroscience Vol 101(3) Jun 1987, 429-432.
• Beckwith, B. E., Petros, T. V., Bergloff, P. J., Swenson, R. R., & et al. (1995). Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers: Peptides Vol 16(8) 1995, 1327-1328.
• Beckwith, B. E., Petros, T. V., Couk, D. I., & Tinius, T. P. (1990). The effects of vasopressin on memory in healthy young adult volunteers: Theoretical and methodological issues. New York, NY: New York Academy of Sciences.
• Beckwith, B. E., Till, R. E., Reno, C. R., & Poland, R. E. (1990). Dose-dependent effects of DDAVP on memory in healthy young adult males: A preliminary study: Peptides Vol 11(3) May-Jun 1990, 473-476.
• Beckwith, B. E., Till, R. E., & Schneider, V. (1984). Vasopressin analog (DDAVP) improves memory in human males: Peptides Vol 5(4) Jul-Aug 1984, 819-822.
• Beckwith, B. E., & Tinius, T. P. (1985). Vasopressin and vasotocin facilitate reversal of a brightness discrimination: Peptides Vol 6(3) May-Jun 1985, 383-386.
• Beckwith, B. E., Tinius, T. P., & Miller, D. H. (1987). Arginine vasopressin facilitates reversal and impairs retention of a brightness discrimination in albino rats: Psychobiology Vol 15(4) Dec 1987, 329-335.
• Beiderbeck, D. I., Neumann, I. D., & Veenema, A. H. (2007). Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety: European Journal of Neuroscience Vol 26(12) Dec 2007, 3597-3605.
• Bell, J., Adler, M. W., Greenstein, J. I., & Liu-Chen, L.-y. (1993). Identification and characterization of: Life Sciences Vol 52(1) 1993, 95-105.
• Bellemere, G., Vaudry, H., Morain, P., & Jegou, S. (2005). Effect of Prolyl Endopeptidase Inhibition on Arginine- Vasopressin and Thyrotrophin-Releasing Hormone Catabolism in the Rat Brain: Journal of Neuroendocrinology Vol 17(5) May 2005, 306-313.
• Belmaker, R. H., & Bleich, A. (1986). The use of desmopressin in adult enuresis: Military Medicine Vol 151(12) Dec 1986, 660-662.
• Bennett, J. A., Keck, P. E., & Wallhausser, L. J. (1994). Desmopressin for risperidone-induced enuresis: Annals of Clinical Psychiatry Vol 6(2) Jun 1994, 139-140.
• Bernardo, M., Gaya, J., Escobar, R., Parellada, E., & et al. (1993). Hypophyseal response to ECT: A higher and faster vasopressin peak: Biological Psychiatry Vol 33(8-9) Apr-May 1993, 670-672.
• Bernstein, H.-G., Schwarzberg, H., Poeggel, G., & Reiser, M. (1994). Intracerebroventricular but not intraperitoneal administration of aluminum attenuates vasopressin-enhanced retrieval of a passive avoidance task in rats: Pharmacology, Biochemistry and Behavior Vol 47(3) Mar 1994, 587-590.
• Berrettini, W. H., & et al. (1982). Platelet vasopressin receptors in bipolar affective illness: Psychiatry Research Vol 7(1) Aug 1982, 83-86.
• Bester-Meredith, J. K. (2002). The effects of the social environment during development on arginine vasopressin, aggression, and paternal behavior. Dissertation Abstracts International: Section B: The Sciences and Engineering.
• Bester-Meredith, J. K., & Marler, C. A. (2001). Vasopressin and aggression in cross-fostered California mice (Peromyscus californicus) and white-footed mice (Peromyscus leucopus): Hormones and Behavior Vol 40(1) Aug 2001, 51-64.
• Bester-Meredith, J. K., & Marler, C. A. (2003). Vasopressin and the transmission of paternal behavior across generations in mated, cross-fostered Peromyscus mice: Behavioral Neuroscience Vol 117(3) Jun 2003, 455-463.
• Bester-Meredith, J. K., Martin, P. A., & Marler, C. A. (2005). Manipulations of Vasopressin Alter Aggression Differently Across Testing Conditions in Monogamous and Non-Monogamous Peromyscus Mice: Aggressive Behavior Vol 31(2) Mar-Apr 2005, 189-199.
• Bester-Meredith, J. K., Young, L. J., & Marler, C. A. (1999). Species differences in paternal behavior and aggression in Peromyscus and their associations with vasopressin immunoreactivity and receptors: Hormones and Behavior Vol 36(1) Aug 1999, 25-38.
• Bielsky, I. F., Hu, S.-B., Szegda, K. L., Westphal, H., & Young, L. J. (2004). Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice: Neuropsychopharmacology Vol 29(3) Mar 2004, 483-493.
• Bielsky, I. F., Hu, S.-B., & Young, L. J. (2005). Sexual dimorphism in the vasopressin system: Lack of an altered behavioral phenotype in female V1a receptor knockout mice: Behavioural Brain Research Vol 164(1) Oct 2005, 132-136.
• Bielsky, I. F., & Young, L. J. (2004). Oxytocin, vasopressin, and social recognition in mammals: Peptides Vol 25(9) Sep 2004, 1565-1574.
• Bierwolf, C., Struve, K., Marshall, L., Born, J., & Fehm, H. L. (1997). Slow Wave Sleep Drives Inhibition of Pituitary-Adrenal Secretion in Humans: Journal of Neuroendocrinology Vol 9(6) Jun 1997, 479-484.
• Bikbulatova, L. S., Orlova, N. V., & Devyatov, S. B. (1987). Participation of genetic apparatus of hippocampal and neocortical cells in mechanisms of action of desglycyl-argininevasopressin on the process of learning and memory in rats: Zhurnal Vysshei Nervnoi Deyatel'nosti Vol 37(6) Nov-Dec 1987, 1075-1080.
• Blanchard, R. J., Griebel, G., Farrokhi, C., Markham, C., Yang, M., & Blanchard, D. C. (2005). AVP V-sub(1b) selective antagonist SSR149415 blocks aggressive behaviors in hamsters: Pharmacology, Biochemistry and Behavior Vol 80(1) Jan 2005, 189-194.
• Bluthe, R. M., Dantzer, R., & le Moal, M. (1985). Peripheral injections of vasopressin control behavior by way of interoceptive signals for hypertension: Behavioural Brain Research Vol 18(1) Oct-Nov 1985, 31-39.
• Bluthe, R.-M., & Dantzer, R. (1990). Social recognition does not involve vasopressinergic neurotransmission in female rats: Brain Research Vol 535(2) Dec 1990, 301-304.
• Bluthe, R.-M., & Dantzer, R. (1992). Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate social recognition in rat: Brain Research Vol 572(1-2) Feb 1992, 261-264.
• Bluthe, R.-M., & Dantzer, R. (1993). Role of the vomeronasal system in vasopressinergic modulation of social recognition in rats: Brain Research Vol 604(1-2) Feb 1993, 205-210.
• Bluthe, R.-M., Dantzer, R., Mormede, P., & le Moal, M. (1985). Specificity of aversive stimulus properties of vasopressin: Psychopharmacology Vol 87(2) Oct 1985, 238-241.
• Bluthe, R.-M., Gheusi, G., & Dantzer, R. (1993). Gonadal steroids influence the involvement of arginine vasopressin in social recognition in mice: Psychoneuroendocrinology Vol 18(4) 1993, 323-335.
• Bluthe, R.-M., Koob, G. F., & Dantzer, R. (1991). Hypertonic saline mimics the effects of vasopressin and social recognition in rats: Behavioural Pharmacology Vol 2(6) Dec 1991, 513-516.
• Bluthe, R.-M., Schoenen, J., & Dantzer, R. (1990). Androgen-dependent vasopressinergic neurons are involved in social recognition in rats: Brain Research Vol 519(1-2) Jun 1990, 150-157.
• Boakes, R. J., & et al. (1985). Abnormal behavioural changes associated with vasopressin-induced barrel rotations: Brain Research Vol 326(1) Feb 1985, 65-70.
• Boccia, M. M., Kopf, S. R., & Baratti, C. M. (1996). The enhancement of retention performance induced by picrotoxin in mice may be mediated through a release of endogenous vasopressin: Behavioural Pharmacology Vol 7(3) May 1996, 254-260.
• Boccia, M. M., Kopf, S. R., & Baratti, C. M. (1998). Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice: Neurobiology of Learning and Memory Vol 69(2) Mar 1998, 136-146.
• Bodnar, R. J., & et al. (1982). Modulation of nociceptive thresholds by vasopressin in the Brattleboro and normal rat: Annals of the New York Academy of Sciences Vol 394 Oct 1982, 735-739.
• Bodnar, R. J., Truesdell, L. S., & Nilaver, G. (1985). Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate: Peptides Vol 6(4) Jul-Aug 1985, 621-626.
• Boer, G. J. (1985). Vasopressin and brain development: Studies using the Brattleboro rat: Peptides Vol 6(Suppl 1) 1985, 49-62.
• Boer, G. J., & et al. (1982). The regional impairment of brain development in the Brattleboro diabetes insipidus rat: Some vasopressin supplementation studies: Annals of the New York Academy of Sciences Vol 394 Oct 1982, 703-717.
• Boer, G. J., Feenstra, M. G. P., Botterblom, M. J. A., Korse, V., & et al. (1995). Early postnatal appearance of enhanced noradrenaline content in the brain of vasopressin-deficient Brattleboro rat: Normal adrenoceptor densities and aberrant influences of vasopressin treatment: International Journal of Developmental Neuroscience Vol 13(2) Apr 1995, 63-74.
• Boer, G. J., Quak, J., De Vries, M. C., & Heinsbroek, R. P. W. (1994). Mild sustained effects of neonatal vasopressin and oxytocin treatment on brain growth and behavior of the rat: Peptides Vol 15(2) 1994, 229-236.
• Bogdanov, A. V. (1984). Effect of vasopressin desglycil-8-arginin on the activity of cortical neurones in alert cats: Zhurnal Vysshei Nervnoi Deyatel'nosti Vol 34(4) 1984, 797-799.
• Bohnen, N., Terwel, D., Twijnstra, A., Markerink, M., & et al. (1992). Effects of apprehension of lumbar puncture procedure on salivary cortisol, plasma vasopressin and osmolality in man: Stress Medicine Vol 8(4) Oct 1992, 253-257.
• Bohnen, N. I., Twijnstra, A., & Jolles, J. (1993). A controlled trial with vasopressin analogue (DGAVP) on cognitive recovery immediately after head trauma: Neurology Vol 43(1) Jan 1993, 103-106.
• Bohus, B. (1977). Effects of desglycinamide-lysine vasopressin (DG-LVP) on sexually motivated T-maze behavior of the male rat: Hormones and Behavior Vol 8(1) Feb 1977, 52-61.
• Bohus, B. (1980). Vasopressin, oxytocin and memory: Effects on consolidation and retrieval processes: Acta Psychiatrica Belgica Vol 80(5) Sep-Oct 1980, 714-720.
• Bohus, B., Ader, R., & de Wied, D. (1972). Effects of vasopressin on active and passive avoidance behavior: Hormones and Behavior Vol 3(3) Sep 1972, 191-197.
• Bohus, B., Borrell, J., Koolhaas, J. M., Nyakas, C., Buwalda, B., Compaan, J. C., et al. (1993). The neurohypophysial peptides, learning, and memory processing. New York, NY: New York Academy of Sciences.
• Bohus, B., Kovacs, G. L., & de Wied, D. (1978). Oxytocin, vasopressin and memory: Opposite effects on consolidation and retrieval processes: Brain Research Vol 157(2) Nov 1978, 414-417.
• Bohus, B., Urban, I., Van Wimersma Greidanus, T. B., & de Wied, D. (1978). Opposite effects of oxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat: Neuropharmacology Vol 17(4-5) Apr-May 1978, 239-247.
• Bookin, H. B., & Pfeifer, W. D. (1977). Effect of lysine vasopressin on pentylenetetrazol-induced retrograde amnesia in rats: Pharmacology, Biochemistry and Behavior Vol 7(1) Jul 1977, 51-54.
• Born, J., Bothor, R., Pietrowsky, R., Fehm-Wolfsdorf, G., & et al. (1987). Influences of vasopressin and oxytocin on human event-related brain potentials in an attention task: Journal of Psychophysiology Vol 1(4) 1987, 351-360.
• Born, J., & Fehm, H. L. (1988). The hormonal modulation of stimulus processing in humans: German Journal of Psychology Vol 12(4) Dec 1988, 315-331.
• Born, J., Fehm-Wolfsdorf, G., Lutzenberger, W., Voigt, K. H., & et al. (1986). Vasopressin and electrophysiological signs of attention in man: Peptides Vol 7(2) Mar-Apr 1986, 189-193.
• Bosch, O. J., Kromer, S. A., & Neumann, I. D. (2006). Prenatal stress: Opposite effects on anxiety and hypothalamic expression of vasopressin and corticotropin-releasing hormone in rats selectively bred for high and low anxiety: European Journal of Neuroscience Vol 23(2) Jan 2006, 541-551.
• Boyd, S. K., & Moore, F. L. (1992). Sexually dimorphic concentrations of arginine vasotocin in sensory regions of the amphibian brain: Brain Research Vol 588(2) Aug 1992, 304-306.
• Brambilla, F. (1990). Hormonal neuropeptides in the treatment of schizophrenia: Rivista di Psichiatria Vol 25(4) Oct-Dec 1990, 175-180.
• Brambilla, F., Aguglia, E., Massironi, R., Maggioni, M., & et al. (1986). Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration: Neuropsychobiology Vol 15(3-4) Sep 1986, 114-121.
• Brambilla, F., Bondiolotti, G. P., Maggioni, M., Sciascia, A., & et al. (1988). Vasopressin (DDAVP) therapy in chronic schizophrenia: Effects on negative symptoms and memory: Neuropsychobiology Vol 20(3) 1988, 113-119.
• Brinton, R. D., Gonzalez, T. M., & Cheung, W. S. (1994). Vasopressin-induced calcium signaling in cultured hippocampal neurons: Brain Research Vol 661(1-2) Oct 1994, 174-180.
• Brinton, R. E. (1985). Neuropharmacological investigation of vasopressin, a putative memory neural peptide: Dissertation Abstracts International.
• Brito, G. N. (1983). The behavior of vasopressin-deficient rats (Brattleboro strain): Physiology & Behavior Vol 30(1) Jan 1983, 29-34.
• Brito, G. N. (1985). Operant behavior and drinking suppression in vasopressin-deficient rats (Brattleboro strain): Behavioural Brain Research Vol 15(1) Jan 1985, 71-74.
• Brito, G. N., Thomas, G. J., Gash, D. M., & Kitchen, J. H. (1982). The behavior of Brattleboro rats: Annals of the New York Academy of Sciences Vol 394 Oct 1982, 740-752.
• Broberg, D. J. (1990). Insulin and vasopressin responses to food presentation in women with eating disorders: Dissertation Abstracts International.
• Broberg, D. J., Dorsa, D. M., & Bernstein, I. L. (1990). Nausea in bulimic women in response to palatable food: Journal of Abnormal Psychology Vol 99(2) May 1990, 183-188.
• Brot, M. D. (1992). Interactions of gonadal steroids with brain vasopressin systems: Implications for a sexually dimorphic behavior: Dissertation Abstracts International.
• Brot, M. D., Bernstein, I. L., & Dorsa, D. M. (1992). Vasopressin deficiency abolishes a sexually dimorphic behavior in Brattleboro rats: Physiology & Behavior Vol 51(4) Apr 1992, 839-843.
• Brot, M. D., de Vries, G. J., & Dorsa, D. M. (1993). Local implants of testosterone metabolites regulate vasopressin mRNA in sexually dimorphic nuclei of the rat brain: Peptides Vol 14(5) Sep-Oct 1993, 933-940.
• Brown, C. H., & Leng, G. (2000). In Vivo Modulation of Post-Spike Excitability in Vasopressin Cells by kappa -Opioid Receptor Activation: Journal of Neuroendocrinology Vol 12(8) Aug 2000, 711-714.
• Brown, M. H., & Nunez, A. A. (1989). Vasopressin-deficient rats show a reduced amplitude of the circadian sleep rhythm: Physiology & Behavior Vol 46(4) Oct 1989, 759-762.
• Brownson, E. A., Brinton, R. D., & Chambers, K. C. (2002). Vasopressin content in select brain regions during extinction of a conditioned taste aversion: Brain Research Bulletin Vol 59(2) Oct 2002, 125-134.
• Bruins, J., Hijman, R., & Van Ree, J. M. (1992). Effect of a single dose of des-glycinamide-[Arg-8]vasopressin or oxytocin on cognitive processes in young healthy subjects: Peptides Vol 13(3) May-Jun 1992, 461-468.
• Bruins, J., Hijman, R., & Van Ree, J. M. (1995). Effect of acute and chronic treatment with desglycinamide-[Arg-8]vasopressin in young male and female volunteers: Peptides Vol 16(2) 1995, 179-186.
• Bruins, J., Kovacs, G. L., Abbes, A. P., Burbach, J. P. H., van den Akker, E. L. T., Engel, H., et al. (2006). Minor disturbances in central nervous system function in familial neurohypophysial diabetes insipidus: Psychoneuroendocrinology Vol 31(1) Jan 2006, 80-91.
• Bruins, J., Kumar, A., & Schneider-Helmert, D. (1990). Influence of desglycinamide-(Arg-8) vasopressin on memory in healthy subjects: Neuropsychobiology Vol 23(2) 1990, 82-88.
• Brunner, J., Keck, M. E., Landgraf, R., Uhr, M., Namendorf, C., & Bronisch, T. (2002). Vasopressin in CSF and plasma in depressed suicide attempters: Preliminary results: European Neuropsychopharmacology Vol 12(5) Oct 2002, 489-494.
• Bugajski, J., Borycz, J., Glod, R., & Bugajski, A. J. (1995). Crowding stress impairs the pituitary-adrenocortical responsiveness to the vasopressin but not corticotropin-releasing hormone stimulation: Brain Research Vol 681(1-2) May 1995, 223-228.
• Bugajski, J., Olowska, A., Gadek-Michalska, A., & Borycz, J. (1995). Effect of indomethacin on the CRH and VP-induced pituitary-adrenocortical response during social stress: Life Sciences Vol 58(5) Dec 1995, PL67-PL72.
• Buijs, R. M., Pevet, P., Masson-Pevet, M., Pool, C. W., & et al. (1986). Seasonal variation in vasopressin innervation in the brain of the European hamster (Cricetus cricetus): Brain Research Vol 371(1) Apr 1986, 193-196.
• Bult, A., Hiestand, L., Van der Zee, E. A., & Lynch, C. B. (1993). Circadian rhythms differ between selected mouse lines: A model to study the role of vasopressin neurons in the suprachiasmatic nuclei: Brain Research Bulletin Vol 32(6) 1993, 623-627.
• Bult, A., Van der Zee, E. A., Compaan, J. C., & Lynch, C. B. (1992). Differences in the number of arginine-vasopressin-immunoreactive neurons exist in the suprachiasmatic nuclei of house mice selected for differences in nest-building behavior: Brain Research Vol 578(1-2) Apr 1992, 335-338.
• Bunsey, M., Kramer, D., Kesler, M., & Strupp, B. J. (1990). A vasopressin metabolite increases attentional selectivity: Behavioral Neuroscience Vol 104(2) Apr 1990, 277-287.
• Bunsey, M., & Strupp, B. J. (1990). A vasopressin metabolite produces qualitatively different effects on memory retrieval depending on the accessibility of the memory: Behavioral & Neural Biology Vol 53(3) May 1990, 346-355.
• Bunsey, M. D. (1992). Assessment of the effects of vasopressinergic and noradrenergic drugs on cognitive processes using novel behavioral tasks: Dissertation Abstracts International.
• Buresova, O., & Skopkova, J. (1982). Vasopressin analogues and spatial working memory in the 24-arm radial maze: Peptides Vol 3(5) Sep-Oct 1982, 725-727.
• Burish, T. G., & et al. (1981). Improved cognitive functioning in central diabetes insipidus following therapy with a vasopressin analogue: Clinical Neuropsychology Vol 3(4) 1981, 13-15.
• Burke, D., & Fanker, S. (1996). Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): Australian and New Zealand Journal of Psychiatry Vol 30(2) Apr 1996, 295-298.
• Burke, D., & Fanker, S. (1996). Fluoxetine-induced SIADH: Most likely in the elderly? : Australian and New Zealand Journal of Psychiatry Vol 30(2) Apr 1996, 299-301.
• Burlet, A., Desor, D., Max, J. P., Nicolas, J. P., & et al. (1990). Ingestive behaviors of the rat deficient in vasopressin synthesis (Brattleboro strain): Effect of chronic treatment by dDAVP: Physiology & Behavior Vol 48(6) Dec 1990, 813-819.
• Burlet, A. J., Jhanwar-Uniyal, M., Chapleur-Chateau, M., Burlet, C. R., & et al. (1992). Effect of food deprivation and refeeding on the concentration of vasopressin and oxytocin in discrete hypothalamic sites: Pharmacology, Biochemistry and Behavior Vol 43(3) Nov 1992, 897-905.
• Burnard, D. M., Pittman, Q. J., & Veale, W. L. (1983). Increased motor disturbances in response to arginine vasopressin following hemorrhage or hypertonic saline: Evidence for central AVP release in rats: Brain Research Vol 273(1) Aug 1983, 59-65.
• Burnard, D. M., Pittman, Q. J., & Veale, W. L. (1985). Brattleboro rats display increased sensitivity to arginine vasopressin-induced motor disturbances: Brain Research Vol 343(2) Sep 1985, 316-322.
• Burnard, D. M., Veale, W. L., & Pittman, Q. J. (1986). Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist: Brain Research Vol 362(1) Jan 1986, 40-46.
• Buschmann, J., Leppla-Wollsiffer, G., Nemeth, N., Nelson, K., & Kirsten, R. (1996). Migraine patients show increased platelet vasopressin receptors: Headache: The Journal of Head and Face Pain Vol 36(10) Nov-Dec 1996, 586-588.
• Buwalda, B., Koolhaas, J. M., & Bohus, B. (1992). Behavioral and cardiac responses to mild stress in young and aged rats: Effects of amphetamine and vasopressin: Physiology & Behavior Vol 51(2) Feb 1992, 211-216.
• Buwalda, B., Nyakas, C., Koolhaas, J. M., & Bohus, B. (1991). Effects of neonatal administration of vasopressin on cardiac and behavioral responses to emotional stress in adult male rats: Physiology & Behavior Vol 50(5) Nov 1991, 929-932.
• Buwalda, B., Nyakas, C., Koolhaas, J. M., & Bohus, B. (1993). Neuroendocrine and behavioral effects of vasopressin in resting and mild stress conditions: Physiology & Behavior Vol 54(5) Nov 1993, 947-953.
• Buwalda, B., Nyakas, C., Koolhaas, J. M., Luiten, P. G., & et al. (1992). Vasopressin prolongs behavioral and cardiac responses to mild stress in young but not in aged rats: Physiology & Behavior Vol 52(6) Dec 1992, 1127-1131.
• Cain, D. P., Plant, J., Rouleau, S., & Corcoran, M. E. (1986). Failure to kindle seizures after repeated intracerebral administration of arginine vasopressin: Life Sciences Vol 38(11) Mar 1986, 985-989.
• Caldwell, H. K., & Albers, H. E. (2003). Short-Photoperiod Exposure Reduces Vasopressin (V-sub(1a)) Receptor Binding But Not Arginine-Vasopressin-lnduced Flank Marking in Male Syrian Hamsters: Journal of Neuroendocrinology Vol 15(10) Oct 2003, 971-977.
• Caldwell, H. K., & Albers, H. E. (2004). Effect of photoperiod on vasopressin-induced aggression in Syrian hamsters: Hormones and Behavior Vol 46(4) Nov 2004, 444-449.
• Car, H., Borawska, M., & Wisniewski, K. (1995). The effect of vasopressin analogue: Acta Neurobiologiae Experimentalis Vol 55(3) 1995, 207-211.
• Car, H., & Murtazina, E. (1994). Studies on arginine-vasopressin and its analogue: Asia Pacific Journal of Pharmacology Vol 9(3) Sep 1994, 149-152.
• Carey, R. J., & Miller, M. (1982). Absence of learning and memory deficits in the vasopressin-deficient rat (Brattleboro strain): Behavioural Brain Research Vol 6(1) Sep 1982, 1-13.
• Carroll, B. T., Meller, W. H., Kathol, R. G., Gehris, T. L., & et al. (1993). Pituitary-adrenal axis response to arginine vasopressin in patients with major depression: Psychiatry Research Vol 46(2) Feb 1993, 119-126.
• Carter, C. S. (2007). Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? : Behavioural Brain Research Vol 176(1) Jan 2007, 170-186.
• Carter, D. A., & Lightman, S. L. (1987). Modulation of oxytocin secretion by ascending noradrenergic pathways: Sexual dimorphism in rats: Brain Research Vol 406(1-2) Mar 1987, 313-316.
• Carter, D. A., & Lightman, S. L. (1987). Oxytocin stress responses are dependent upon emotionality: Psychoneuroendocrinology Vol 12(3) 1987, 219-223.
• Carter, J. S., Williams, H. G., Davis, J. M., & French, K. E. (1991). Effects of DDAVP on movement planning and execution processes in the healthy elderly: Peptides Vol 12(4) Jul-Aug 1991, 871-876.
• Carter, J. S., Williams, H. G., Davis, J. M., & Rotter, R. A. (1991). Effects of DDAVP on movement planning and execution processes in healthy young adults: Peptides Vol 12(1) Jan-Feb 1991, 1-5.
• Castagna, C., Absil, P., Foidart, A., & Balthazart, J. (1998). Systemic and intracerebroventricular injections of vasotocin inhibit appetitive and consummatory components of male sexual behavior in Japanese quail: Behavioral Neuroscience Vol 112(1) Feb 1998, 233-250.
• Cates, P. S., Forsling, M. L., & O'Byrne, K. T. (1999). Stress-Induced Suppression of Pulsatile Luteinising Hormone Release in the Female Rat: Role of Vasopressin: Journal of Neuroendocrinology Vol 11(9) Sep 1999, 677-683.
• Chambers, W. F., & et al. (1966). Effect of vasopressin and adrenal steroids on cortical response evoked at the midbrain level in aged rats: Gerontologia 12(2) 1966, 65-73.
• Chen, M.-D., Ordog, T., & Knobil, E. (1998). Mitigation of the somnolence of insulin-induced hypoglycemia by a vasopressin V-sub-1 receptor antagonist in the rhesus monkey: Psychoneuroendocrinology Vol 23(5) Jul 1998, 497-503.
• Chen, S., Sui, N., Guan, L., Kuang, P., & et al. (1994). Vasopressin and memory retention in one-day old chicks: Acta Psychologica Sinica Vol 26(3) 1994, 284-288.
• Chen, X.-f., Chen, Z.-f., Liu, R.-y., & Du, Y.-c. (1988). Neonatal administrations of a vasopressin analog (DDAVP) and hypertonic saline enhance learning behavior in rats: Peptides Vol 9(4) Jul-Aug 1988, 717-721.
• Chepkova, A. N., French, P., de Wied, D., Ontskul, A. H., & et al. (1995). Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8): Brain Research Vol 701(1-2) Dec 1995, 255-266.
• Cherkas, L. F., Oelsner, E. C., Mak, Y. T., Valdes, A., & Spector, T. D. (2004). Genetic Influences on Female Infidelity and Number of Sexual Partners in Humans: A Linkage and Association Study of the Role of the Vasopressin Receptor Gene (AVPR1A): Twin Research Vol 7(6) Dec 2004, 649-658.
• Cho, M. M., DeVries, A. C., Williams, J. R., & Carter, C. S. (1999). The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster): Behavioral Neuroscience Vol 113(5) Oct 1999, 1071-1079.
• Christensen, S. (1976). Acute and chronic effecs of vasopressin in rats with lithium-polyuria: Acta Pharmacologica et Toxicologica Vol 38(3) Mar 1976, 241-253.
• Claudine, S.-L. G., Sylvain, D., Gabrielle, B., Maurice, M., Jacques, S., Rolf, G., et al. (2003). Functional and Pharmacological Characterization of the First Specific Agonist and Antagonist for the V1b Receptor in Mammals: Stress: The International Journal on the Biology of Stress Vol 6(3) Sep 2003, 199-206.
• Coccaro, E. F., Kavoussi, R. J., Hauger, R. L., Cooper, T. B., & Ferris, C. F. (1998). Cerebrospinal fluid vasopressin levels: Correlates with aggression and serotonin function in personality-disordered subjects: Archives of General Psychiatry Vol 55(8) Aug 1998, 708-714.
• Cohen, S. L., Knight, M., Tamminga, C. A., & Chase, T. N. (1985). Effects of vasopressin on multiple fixed-ratio fixed-interval schedules of reinforcement: Bulletin of the Psychonomic Society Vol 23(6) Nov 1985, 531-534.
• Colombo, G., Hansen, C., Hoffman, P. L., & Grant, K. A. (1992). Decreased performance in a delayed alternation task by rats genetically deficient in vasopressin: Physiology & Behavior Vol 52(4) Oct 1992, 827-830.
• Compaan, J. C., Buijs, R. M., Pool, C. W., de Ruiter, A. J., & et al. (1993). Differential lateral septal vasopressin innervation in aggressive and nonaggressive male mice: Brain Research Bulletin Vol 30(1-2) 1993, 1-6.
• Connan, F., Lightman, S. L., Landau, S., Wheeler, M., Treasure, J., & Campbell, I. C. (2007). An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: The role of CRH and AVP: Journal of Psychiatric Research Vol 41(1-2) Jan-Feb 2007, 131-143.
• Cooper, M. A., Karom, M., Huhman, K. L., & Albers, H. E. (2005). Repeated agonistic encounters in hamsters modulate AVP V1a receptor binding: Hormones and Behavior Vol 48(5) Dec 2005, 545-551.
• Cooper, R. L., McNamara, M. C., Thompson, W. G., & Marsh, G. R. (1980). Vasopressin modulation of learning and memory in the rat. Washington, DC: American Psychological Association.
• Corcoran, M. E., Cain, D. P., Finlay, J. M., & Gillis, B. J. (1984). Vasopressin and the kindling of seizures: Life Sciences Vol 35(9) Aug 1984, 947-952.
• Corson, S. A., Corson, E. O., Hajek, J., & Hajkova, M. (1977). The function of vasopressin in adaptation to emotional stress: Activitas Nervosa Superior Vol 19(4) 1977, 302-304.
• Couk, D. I. (1987). Vasopressin analogues and their effects upon arousal, attention and memory: Dissertation Abstracts International.
• Couk, D. I., & Beckwith, B. E. (1982). Effects of desmopressin acetate (DDAVP) on the learning of a brightness discrimination: Peptides Vol 3(3) May-Jun 1982, 521-526.
• Crabbe, J. C., & Rigter, H. (1985). Vasopressin and ethanol preference: II. Altered preference in two strains of diabetes insipidus rats and nephrogenic diabetes insipidus mice: Peptides Vol 6(4) Jul-Aug 1985, 677-683.
• Crabbe, J. C., Rigter, H., & Kerbusch, S. (1980). Genetic analysis of tolerance to ethanol hypothermia in recombinant inbred mice: Effect of desglycinamide(-9)-arginine(-8)-vasopressin: Behavior Genetics Vol 10(2) Mar 1980, 139-152.
• Crine, A. F. (1981). Effects of vasopressin on open-field behavior in rats: Physiological Psychology Vol 9(1) Mar 1981, 109-113.
• Crine, A. F. (1982). Effect of a high dose of vasopressin on an inhibition avoidance response: Progress in Neuro-Psychopharmacology & Biological Psychiatry Vol 6(3) 1982, 265-268.
• Crine, A. F. (1983). On the possible role played by vasopressin in paraventricular nucleus-feeding behavior relationship: Hormones and Behavior Vol 17(3) Sep 1983, 342-343.
• Crine, A. F. (1984). Dose-related influence of arginine-vasopressin on a passive avoidance behavior: Effect of rearing conditions: Progress in Neuro-Psychopharmacology & Biological Psychiatry Vol 8(3) 1984, 379-384.
• Crine, A. F. (1984). Vasopressin effects on food-rewarded learning tasks might be due to its action on carbohydrate/lipid metabolism, not memory: Appetite Vol 5(3) Sep 1984, 233-238.
• Crine, A. F., Bredart, S., & Legros, J. J. (1981). Effect of exogenous arginine vasopressin on rectal temperature in the albino rat: Hormones and Behavior Vol 15(2) Jun 1981, 226-231.
• Crine, A. F., & Buijs, R. M. (1987). Electric footshocks differentially affect plasma and spinal cord vasopressin and oxytocin levels: Peptides Vol 8(2) Mar-Apr 1987, 243-246.
• Crowe, S. F., Ng, K. T., & Gibbs, M. E. (1990). Memory consolidation of weak training experiences by hormonal treatments: Pharmacology, Biochemistry and Behavior Vol 37(4) Dec 1990, 729-734.
• Cushing, B. S., Martin, J. O., Young, L. J., & Carter, C. S. (2001). The effects of peptides on partner preference formation are predicted by habitat in prairie voles: Hormones and Behavior Vol 39(1) Feb 2001, 48-58.
• Cushing, B. S., Okorie, U., & Young, L. J. (2003). The Effects of Neonatal Castration on the Subsequent Behavioural Response to Centrally Administered Arginine Vasopressin and the Expression of V-sub(1a) Receptors in Adult Male Prairie Voles: Journal of Neuroendocrinology Vol 15(11) Nov 2003, 1021-1026.
• Danguir, J. (1983). Sleep deficits in rats with hereditary diabetes insipidus: Nature Vol 304(5922) Jul 1983, 163-164.
• Dantzer, R. (2006). Review of The roles of vasopressin and oxytocin in memory processing: Psychoneuroendocrinology Vol 31(2) Feb 2006, 275-276.
• Dantzer, R., Bluthe, R. M., Koob, G. F., & le Moal, M. (1987). Modulation of social memory in male rats by neurohypophyseal peptides: Psychopharmacology Vol 91(3) Mar 1987, 363-368.
• Dantzer, R., Bluthe, R.-M., & Kelley, K. W. (1991). Androgen-dependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior: Brain Research Vol 557(1-2) Aug 1991, 115-120.
• Dantzer, R., Koob, G. F., Bluthe, R.-M., & le Moal, M. (1988). Septal vasopressin modulates social memory in male rats: Brain Research Vol 457(1) Aug 1988, 143-147.
• Davis, B. M., & et al. (1982). Effects of cholinergic stimulation on pituitary hormone release: Psychoneuroendocrinology Vol 7(4) Dec 1982, 347-354.
• Davis, J. L. (1984). Effects of a vasopressin analogue, DDAVP, on chick memory: IRCS Medical Science: Psychology & Psychiatry Vol 12(9-10) Sep-Oct 1984, 865.
• Davis, J. L., Pico, R. M., & Cherkin, A. (1982). Arginine vasopressin enhances memory retroactively in chicks: Behavioral & Neural Biology Vol 35(3) Jul 1982, 242-250.
• Davis, J. L., Pico, R. M., & Cherkin, A. (1983). L-prolyl-L-arginyl-glycineamide induces memory enhancement in chicks: Peptides Vol 4(4) Jul-Aug 1983, 401-404.
• de Arruda Camargo, G. M. P., de Arruda Camargo, L. A., & Saad, W. A. (2007). Vasopressin and angiotensin receptors of the medial septal area of the brain in the control of thirst and salt appetite induced by vasopressin in water-deprived and sodium-depleted rats: Pharmacology, Biochemistry and Behavior Vol 87(4) Oct 2007, 393-399.
• de Bellis, M. D., Gold, P. W., Geracioti, T. D., Listwak, S. J., & et al. (1993). Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression: American Journal of Psychiatry Vol 150(4) Apr 1993, 656-657.
• de Goeij, D. C., Jezova, D., & Tilders, F. J. (1992). Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus: Brain Research Vol 577(1) Apr 1992, 165-168.
• de Goeij, D. C. E., Jezova, D., & Tilders, F. J. H. (1992). Chronic stress and adrenalectomy both induce vasopressin synthesis and storage in corticotropin releasing factor neurons in the paraventricular nucleus. Philadelphia, PA, England: Gordon & Breach Science Publishers.
• de Kloet, C. S., Vermetten, E., Geuze, E., Wiegant, V. M., & Westenberg, H. G. M. (2008). Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder: Journal of Psychiatric Research Vol 42(3) Feb 2008, 192-198.
• de Saint Hilaire, Z., Gaillard, J.-M., Sarbach, S. D., & Guez, D. (1995). Effect of a new cognitive drug-enhancer S-12024-2 on EEG sleep recordings in rats: Pharmacology, Biochemistry and Behavior Vol 52(4) Dec 1995, 819-823.
• de Vito, W. J. (1981). The effect of ACTH and vasopressin on extinction: An opiate mediator model: Dissertation Abstracts International.
• De Vries, G. J., Wang, Z., Bullock, N. A., & Numan, S. (1994). Sex differences in the effects of testosterone and its metabolites on vasopressin messenger RNA levels in the bed nucleus of the stria terminalis of rats: Journal of Neuroscience Vol 14(3, Pt 2) Mar 1994, 1789-1794.
• de Vry, J., Donselaar, I., & Van Ree, J. M. (1988). Effects of desglycinamide-9,(ARG-8) vasopressin and vasopressin antiserum on the acquisition of intravenous cocaine self-administration in the rat: Life Sciences Vol 42(26) 1988, 2709-2715.
• de Wied, D. (1976). Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments: Life Sciences Vol 19(5) Sep 1976, 685-690.
• de Wied, D. (1984). The importance of vasopressin in memory: Trends in Neurosciences Vol 7(4) Apr 1984, 109.
• de Wied, D., Gaffori, O., Burbach, J. P., Kovacs, G. L., & et al. (1987). Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors in rats: Journal of Pharmacology and Experimental Therapeutics Vol 241(1) Apr 1987, 268-274.
• de Wied, D., Gaffori, O., Van Ree, J. M., & de Jong, W. (1984). Central target for the behavioural effects of vasopressin neuropeptides: Nature Vol 308(5956) Mar 1984, 276-278.
• de Wied, D., Gaffori, O., Van Ree, J. M., & de Jong, W. (1984). Vasopressin antagonists block peripheral as well as central vasopressin receptors: Pharmacology, Biochemistry and Behavior Vol 21(3) Sep 1984, 393-400.
• De Wied, D., Greven, H. M., Lande, S., & Witter, A. (1972). Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion: British Journal of Pharmacology Vol 45(1) May 1972, 118-122.
• de Wied, D., & Van Ree, J. M. (1989). Neuropeptides: Animal behaviour and human psychopathology: European Archives of Psychiatry & Neurological Sciences Vol 238(5-6) Jul 1989, 323-331.
• de Winter, R. F. P., van Hemert, A. M., DeRijk, R. H., Zwinderman, K. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., et al. (2003). Anxious-retarded depression: Relation with plasma vasopressin and cortisol: Neuropsychopharmacology Vol 28(1) Jan 2003, 140-147.
• de Winter, R. F. P., van Hemert, A. M., DeRijk, R. H., Zwinderman, K. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., et al. (2003). Anxious-retarded depression: Relation with plasma vasopressin and cortisol: Correction: Neuropsychopharmacology Vol 28(3) Mar 2003, 610.
• de Winter, R. F. P., Zitman, F. G., van Houwelingen, J. C., Wolterbeek, R., & Goekoop, J. G. (2006). Anxious-retarded depression: Relation to two-year outcome of major depressive disorder: Journal of Affective Disorders Vol 90(1) Jan 2006, 77-81.
• D'Eath, R. B., Ormandy, E., Lawrence, A. B., Sumner, B. E. H., & Meddle, S. L. (2005). Resident-intruder trait aggression is associated with differences in lysine vasopressin and serotonin receptor 1A (5-HT-sub(1A)) mRNA expression in the brain of pre-pubertal female domestic pigs (Sus scrofa): Journal of Neuroendocrinology Vol 17(10) Oct 2005, 679-686.
• DeLanoy, R. L. (1980). Peptide hormone interactions with brain catecholamine metabolism: Dissertation Abstracts International.
• Delanoy, R. L., Dunn, A. J., & Tintner, R. (1978). Behavioral responses to intracerebroventricularly administered neurohypophyseal peptides in mice: Hormones and Behavior Vol 11(3) Dec 1978, 348-362.
• Delanoy, R. L., Kramarcy, N. R., & Dunn, A. J. (1982). ACTH-B1-24-b and lysine vasopressin selectively activate dopamine synthesis in frontal cortex: Brain Research Vol 231(1) Jan 1982, 117-129.
• Delanoy, R. L., Kramarcy, N. R., & Dunn, A. J. (1982). ACTH-sub(1superscript 24) and lysine vasopressin selectively activate dopamine synthesis in frontal cortex: Brain Research Vol 231(1) Jan 1982, 117-129.
• DeLeon, K. R., Grimes, J. M., & Melloni, R. H., Jr. (2002). Repeated anabolic-androgenic steroid treatment during adolescence increases vasopressin V-sub(1A ) receptor binding in Syrian hamsters: Correlation with offensive aggression: Hormones and Behavior Vol 42(2) Sep 2002, 182-191.
• Delva, N. J., Crammer, J. L., Lawson, J. S., Lightman, S. L., & et al. (1990). Vasopressin in chronic psychiatric patients with primary polydipsia: British Journal of Psychiatry Vol 157 Nov 1990, 703-712.
• Delva, N. J., Lawson, J. S., Lightman, S. L., & Crammer, J. L. (1991). "Vasopressin in polydipsia": Reply: British Journal of Psychiatry Vol 158 Apr 1991, 570.
• Delville, Y., De Vries, G. J., & Ferris, C. F. (2000). Neural connections of the anterior hypothalamus and agonistic behavior in golden hamsters: Brain, Behavior and Evolution Vol 55(2) Feb 2000, 53-76.
• Delville, Y., De Vries, G. J., Schwartz, W. J., & Ferris, C. F. (1998). Flank-marking behavior and the neural distribution of vasopressin innervation in golden hamsters with suprachiasmatic lesions: Behavioral Neuroscience Vol 112(6) Dec 1998, 1486-1501.
• Delville, Y., Koh, E. T., & Ferris, C. F. (1994). Sexual differences in the magnocellular vasopressinergic system in golden hamsters: Brain Research Bulletin Vol 33(5) 1994, 535-540.
• Delville, Y., Mansour, K. M., & Ferris, C. F. (1996). Serotonin blocks vasopressin-facilitated offensive aggression: Interactions within the ventrolateral hypothalamus of golden hamsters: Physiology & Behavior Vol 59(4-5) Apr-May 1996, 813-816.
• Delville, Y., Mansour, K. M., & Ferris, C. F. (1996). Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus: Physiology & Behavior Vol 60(1) Jul 1996, 25-29.
• Delville, Y., Melloni, R. H., Jr., & Ferris, C. F. (1998). Behavioral and neurobiological consequences of social subjugation during puberty in golden hamsters: Journal of Neuroscience Vol 18(7) Apr 1998, 2667-2672.
• Delwaide, P. J., Devoitille, J. M., & Ylieff, M. (1980). Acute effect of drugs upon memory of patients with senile dementia: Acta Psychiatrica Belgica Vol 80(5) Sep-Oct 1980, 748-754.
• Dempster, E. L., Burcescu, I., Wigg, K., Kiss, E., Baji, I., Gadoros, J., et al. (2007). Evidence of an association between the vasopressin V1b receptor gene (AVPRIB) and childhood-onset mood disorders: Archives of General Psychiatry Vol 64(10) Oct 2007, 1189-1195.
• Dessypris, A. (1986). Hormonal responses in long-term physical exercise: Psychiatria Fennica Suppl 1986, 45-53.
• Devanand, D. P., Lisanby, S., Lo, E.-S., Fitzsimons, L., Cooper, T. B., Halbreich, U., et al. (1998). Effects of electroconvulsive therapy on plasma vasopressin and oxytocin: Biological Psychiatry Vol 44(7) Oct 1998, 610-616.
• DeVito, W. J., & Brush, F. R. (1984). Effect of ACTH and vasopressin on extinction: Evidence for opiate mediation: Behavioral Neuroscience Vol 98(1) Feb 1984, 59-71.
• Diamant, M., Baars, A. M., Kovacs, G. L., & De Wied, D. (1994). Barrel rotation induced by central arginine-8-vasopressin treatment: Involvement of neurohypophyseal peptide receptors: Pharmacology, Biochemistry and Behavior Vol 47(1) Jan 1994, 27-32.
• Dietrich, A. (1997). Memory enhancing effects of the vasopressin analog AVP. Dissertation Abstracts International: Section B: The Sciences and Engineering.
• Dietrich, A., & Allen, J. D. (1997). Vasopressin and memory: I. The vasopressin analogue AVP-sub(4-9 ) enhances working memory as well as reference memory in the radial arm maze: Behavioural Brain Research Vol 87(2) Sep 1997, 195-200.
• Dietrich, A., & Allen, J. D. (1997). Vasopressin and memory: II. Lesions to the hippocampus block the memory enhancing effects of AVP-sub(4-9 ) in the radial maze: Behavioural Brain Research Vol 87(2) Sep 1997, 201-208.
• Dietrich, A., Taylor, J. T., & Passmore, C. E. (2001). AVP (4-8) improves concept learning in PFC-damaged but not hippocampal-damaged rats: Brain Research Vol 919(1) Nov 2001, 41-47.
• Dinan, T. G. (2005). Guest editorial: Vasopressin: The neglected target for stress modulation? : Stress and Health: Journal of the International Society for the Investigation of Stress Vol 21(3) Aug 2005, 145-146.
• Dinan, T. G., O'Brien, S., Lavelle, E., & Scott, L. V. (2004). Further neuroendocrine evidence of enhanced vasopressin V-sub-3 receptor responses in melancholic depression: Psychological Medicine Vol 34(1) Jan 2004, 169-172.
• Dittman, R. W., & Wolter, S. (1996). Primary nocturnal enuresis and desmopressin treatment: Do psychosocial factors affect outcome? : European Child & Adolescent Psychiatry Vol 5(2) Jun 1996, 101-109.
• Dluzen, D. E., Muraoka, S., Engelmann, M., & Landgraf, R. (1998). The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats: Peptides Vol 19(6) 1998, 999-1005.
• Dobie, D. J., Miller, M. A., Urban, J. H., Raskind, M. A., & et al. (1991). Age-related decline of vasopressin mRNA in the bed nucleus of the stria terminalis: Neurobiology of Aging Vol 12(5) Sep-Oct 1991, 419-523.
• Dobruch, J., Cudnoch-Jedrzejewska, A., & Szczepanska-Sadowska, E. (2005). Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction: Stress: The International Journal on the Biology of Stress Vol 8(4) Dec 2005, 273-284.
• Dodt, C., Pietrowsky, R., Sewing, A., Zabel, A., & et al. (1994). Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans: Journals of Gerontology Vol 49(4) Jul 1994, M183-M188.
• Donovan, B. T. (1978). The behavioural actions of the hypothalamic peptides: A review: Psychological Medicine Vol 8(2) May 1978, 305-316.
• Dons, R. F., House, J. F., Hood, D., & Krehbiel, M. (1989). Assessment of desmopressin-enhanced cognitive function in a neurosurgical patient: Military Medicine Vol 154(2) Feb 1989, 83-85.
• Dorsa, D. M., & Bottemiller, L. (1982). Age-related changes of vasopressin content of microdissected areas of the rat brain: Brain Research Vol 242(1) Jun 1982, 151-156.
• Drago, F., Stanciu, M., Salehi, S., & Scapagnini, U. (1997). The block of central vasopressin V-sub-1 but not V-sub-2 receptors suppresses grooming behavior and hypothermia induced by intracerebroventricular vasopressin in male rats: Peptides Vol 18(9) 1997, 1389-1392.
• Dreifuss, J. J., Muhlethaler, M., & Gahwiler, B. H. (1982). Electrophysiology of vasopressin in normal rats and in rats of the Brattleboro strain: Annals of the New York Academy of Sciences Vol 394 Oct 1982, 689-702.
• Dubrovina, N. I., Papsuyevich, O. S., & Chipens, G. I. (1991). Slowing of extinction of the conditioned reaction and the antiamnesic effect of arginine-vasopressin and des-glycine-(8-arginine)-vasopressin: Farmakologiya i Toksikologiya Vol 54(5) Sep-Oct 1991, 5-7.
• Durso, R., & et al. (1982). Lysine vasopressin in Alzheimer disease: Neurology Vol 32(6) Jun 1982, 674-677.
• Eames, P., & Wood, R. L. (1999). Lysine vasopressin in post-traumatic memory disorders: An uncontrolled pilot study: Brain Injury Vol 13(4) Apr 1999, 255-260.
• Ebenezer, I. S. (1985). Atropine pretreatment does not reverse the depressant effect of arginine vasopressin on the spontaneous activity of rats: IRCS Medical Science: Psychology & Psychiatry Vol 13(3-4) Mar-Apr 1985, 344-345.
• Ebenezer, I. S. (1985). The development of tolerance to the depressant effect of arginine-8 vasopressin on the spontaneous motor activity of rats: Neuropharmacology Vol 24(11) Nov 1985, 1073-1078.
• Ebenezer, I. S. (1988). Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment? : Neuropharmacology Vol 27(9) Sep 1988, 903-907.
• Ebenezer, I. S. (1993). Effects of arginine-8 vasopressin and lithium chloride on an appetitively motivated task in rats: Medical Science Research Vol 21(3) Feb 1993, 97-98.
• Ebihara, H., Kawasaki, H., Nakamura, S., Takasaki, K., & et al. (1993). Pressor response to microinjection of clonidine into the hypothalamic paraventricular nucleus in conscious rats: Brain Research Vol 624(1-2) Oct 1993, 44-52.
• Ebner, K., Wotjak, C. T., Landgraf, R., & Engelmann, M. (2000). A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats: Brain Research Vol 872(1-2) Jul 2000, 87-92.
• Ebner, K., Wotjak, C. T., Landgraf, R., & Engelmann, M. (2002). Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats: European Journal of Neuroscience Vol 15(2) Jan 2002, 384-388.
• Edelstein, E. L. (1981). Vasopressins and other neuropeptides as CNS mental modulators: A review: Israel Journal of Psychiatry and Related Sciences Vol 18(3) 1981, 229-236.
• Egashira, N., Tanoue, A., Higashihara, F., Fuchigami, H., Sano, K., Mishima, K., et al. (2005). Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: Reversal by antipsychotic drugs: Neuropsychopharmacology Vol 30(11) Nov 2005, 1996-2005.
• Egashira, N., Tanoue, A., Matsuda, T., Koushi, E., Harada, S., Takano, Y., et al. (2007). Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice: Behavioural Brain Research Vol 178(1) Mar 2007, 123-127.
• Ehlers, C. L., & et al. (1985). EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat: Psychopharmacology Vol 87(4) Dec 1985, 430-433.
• Ehrenreich, H., tom Dieck, K., Gefeller, O., Kaw, S., & et al. (1997). Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty: Psychoneuroendocrinology Vol 22(1) Jan 1997, 13-24.
• Ehrensing, R. H., Michell, G. F., & Baker, R. P. (1982). Vasopressin's effects on acquisition and extinction of conditioned avoidance response to smoking: Peptides Vol 3(3) May-Jun 1982, 527-530.
• Eisenberg, J., Chazan-Gologorsky, S., Hattab, J., & Belmaker, R. H. (1984). A controlled trial of vasopressin treatment of childhood learning disorder: Biological Psychiatry Vol 19(7) Jul 1984, 1137-1141.
• Eisenhofer, G., Johnson, R. H., & Lambie, D. G. (1984). Growth hormone, vasopressin, cortisol, and catecholamine responses to insulin hypoglycemia in alcoholics: Alcoholism: Clinical and Experimental Research Vol 8(1) Jan-Feb 1984, 33-36.
• Eisenhofer, G., Lambie, D. G., & Robinson, B. J. (1985). No improvement in ethanol-induced deficits after administration of a vasopressin analog: Life Sciences Vol 37(26) Dec 1985, 2499-2505.
• Eisenhofer, G., Lambie, D. G., Whiteside, E. A., & Johnson, R. H. (1985). Vasopressin concentrations during alcohol withdrawal: British Journal of Addiction Vol 80(2) Jun 1985, 195-199.
• Ekman, R., Gobom, J., Persson, R., Mecocci, P., & Nilsson, C. L. (2001). Arginine vasopressin in the cytoplasm and nuclear fraction of lymphocytes from healthy donors and patients with depression or schizophrenia: Peptides Vol 22(1) Jan 2001, 67-72.
• Elman, I., Lukas, S., Shoaf, S. E., Rott, D., Adler, C., & Breier, A. (2003). Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia: Journal of Psychopharmacology Vol 17(3) Sep 2003, 317-323.
• Emsley, R., Potgieter, A., Taljaard, F., Joubert, G., & et al. (1989). Water excretion and plasma vasopressin in psychotic disorders: American Journal of Psychiatry Vol 146(2) Feb 1989, 250-253.
• Emsley, R. A., Roberts, M. C., Aalbers, C., Taljaard, F. J. J., Kapnias, S., Pieters, H. C., et al. (1995). Vasopressin secretion and memory impairment in alcoholic Korsakoff's syndrome: Alcohol and Alcoholism Vol 30(2) Mar 1995, 223-229.
• Engelmann, M., Ebner, K., Landgraf, R., & Wotjak, C. T. (1998). Swim stress triggers the release of vasopressin within the suprachiasmatic nucleus of male rats: Brain Research Vol 792(2) May 1998, 343-347.
• Engelmann, M., Ebner, K., Landgraf, R., & Wotjak, C. T. (2006). Effects of Morris water maze testing on the neuroendocrine stress response and intrahypothalamic release of vasopressin and oxytocin in the rat: Hormones and Behavior Vol 50(3) Sep 2006, 496-501.
• Engelmann, M., & Landgraf, R. (1994). Is the hypothalamic supraoptic nucleus involved in the neuroendocrine-immune dialogue? : Psychologische Beitrage Vol 36(1-2) 1994, 119-125.
• Engelmann, M., & Landgraf, R. (1994). Is the hypothalamic supraoptic nucleus involved in the neuroendocrinemmune dialogue? : Psychologische Beitrage Vol 36(1-2) 1994, 119-125.
• Engelmann, M., & Landgraf, R. (1994). Microdialysis administration of vasopressin into the septum improves social recognition in Brattleboro rats: Physiology & Behavior Vol 55(1) Jan 1994, 145-149.
• Engelmann, M., & Ludwig, M. (2004). The activity of the hypothalamo-neurohypophysial system in response to acute stressor exposure: Neuroendocrine and electrophysiological observations: Stress: The International Journal on the Biology of Stress Vol 7(2) Jun 2004, 91-96.
• Engelmann, M., Ludwig, M., & Landgraf, R. (1992). Microdialysis administration of vasopressin and vasopressin antagonists into the septum during pole-jumping behavior in rats: Behavioral & Neural Biology Vol 58(1) Jul 1992, 51-57.
• Englemann, M., Wotjak, C. T., Neumann, I., & Ludwig, M. (1996). Behavioral consequences of intracerebral vasopressin and oxytocin: Focus on learning and memory: Neuroscience & Biobehavioral Reviews Vol 20(3) Fal 1996, 341-358.
• Ermisch, A., & Landgraf, R. (1984). Vasopressin, oxytocin, blood-brain barrier and stress: Activitas Nervosa Superior Vol 26(2) 1984, 141-142.
• Ermisch, A., Landgraf, R., & Mobius, P. (1986). Vasopressin and oxytocin in brain areas of rats with high or low behavioral performance: Brain Research Vol 379(1) Jul 1986, 24-29.
• Etienne, P. E., & et al. (1981). Adverse effects of medical and psychiatric workup in six demented geriatric patients: American Journal of Psychiatry Vol 138(4) Apr 1981, 520-521.
• Ettenberg, A. (1984). Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin: Behavioural Brain Research Vol 14(3) Dec 1984, 201-211.
• Ettenberg, A., & et al. (1983). Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? : Behavioural Brain Research Vol 7(3) Mar 1983, 331-350.
• Ettenberg, A., le Moal, M., Koob, G. F., & Bloom, F. E. (1983). Vasopressin potentiation in the performance of a learned appetitive task: Reversal by a pressor antagonist analog of vasopressin: Pharmacology, Biochemistry and Behavior Vol 18(4) Apr 1983, 645-647.
• Everts, H. G. J., De Ruiter, A. J. H., & Koolhaas, J. M. (1997). Differential lateral septal vasopressin in wild-type rats: Correlation with aggression: Hormones and Behavior Vol 31(2) Apr 1997, 136-144.
• Everts, H. G. J., & Koolhaas, J. M. (1997). Lateral septal vasopressin in rats: Role in social and object recognition? : Brain Research Vol 760(1-2) Jun 1997, 1-7.
• Everts, H. G. J., & Koolhaas, J. M. (1999). Differential modulation of lateral septal vasopressin receptor blockade in spatial learning, social recognition, and anxiety-related behaviors in rats: Behavioural Brain Research Vol 99(1) Feb 1999, 7-16.
• Faiman, C. P., de Erausquin, G. A., & Baratti, C. M. (1987). Mecamylamine prevents the enhancement of retention induced by lysine vasopressin in mice: Behavioral & Neural Biology Vol 48(3) Nov 1987, 434-439.
• Faiman, C. P., de Erausquin, G. A., & Baratti, C. M. (1988). Vasopressin modulates the activity of nicotinic cholinergic mechanisms during memory retrieval in mice: Behavioral & Neural Biology Vol 50(1) Jul 1988, 112-119.
• Faiman, C. P., de Erausquin, G. A., & Baratti, C. M. (1991). The enhancement of retention induced by vasopressin in mice may be mediated by an activation of central nicotinic cholinergic mechanisms: Behavioral & Neural Biology Vol 56(2) Sep 1991, 183-199.
• Fehm-Wolfsdorf, G., Bachholz, G., Born, J., Voigt, K., & et al. (1988). Vasopressin but not oxytocin enhances cortical arousal: An integrative hypothesis on behavioral effects of neurohypophyseal hormones: Psychopharmacology Vol 94(4) Apr 1988, 496-500.
• Fehm-Wolfsdorf, G., & Born, J. (1991). Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 years of research: Peptides Vol 12(6) Nov-Dec 1991, 1399-1406.
• Fehm-Wolfsdorf, G., Born, J., Voigt, K., & Fehm, H.-L. (1988). Psychological and electrophysiological evidence for vasopressin effects in human memory. Kirkland, WA: Hans Huber Publishers.
• Fehm-Wolfsdorf, G., Born, J., Voigt, K.-H., & Fehm, H.-L. (1984). Behavioral effects of vasopressin: A single case study: Neuropsychobiology Vol 11(1) 1984, 49-53.
• Fehm-Wolfsdorf, G., Born, J., Voigt, K.-H., & Fehm, H.-L. (1984). Human memory and neurohypophyseal hormones: Opposite effects of vasopressin and oxytocin: Psychoneuroendocrinology Vol 9(3) 1984, 285-292.
• Fehm-Wolfsdorf, G., & et al. (1985). Vasopressin does not enhance memory processes: A study in human twins: Peptides Vol 6(2) Mar-Apr 1985, 297-300.
• Fekete, M., Van Ree, J. M., & de Wied, D. (1986). The ACTH-(4-9) analog ORG 2766 and desglycinamide-9-(Arg-8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats: Peptides Vol 7(4) Jul-Aug 1986, 563-568.
• Fernandas, L. G., Antunes, V. R., Bonagamba, L. G. H., & Machado, B. H. (2005). Pressor response to chemoreflex activation in awake rats: Role of vasopressin and adrenal medulla: Physiology & Behavior Vol 84(1) Jan 2005, 39-44.
• Ferris, C. (1992). Role of vasopressin in aggressive and dominant/subordinate behaviors. New York, NY: New York Academy of Sciences.
• Ferris, C. F. (1996). Serotonin diminishes aggression by suppressing the activity of the vasopressin system. New York, NY: New York Academy of Sciences.
• Ferris, C. F., & Delville, Y. (1994). Vasopressin and serotonin interactions in the control of agonistic behavior: Psychoneuroendocrinology Vol 19(5-7) 1994, 593-601.
• Ferris, C. F., Delville, Y., Bonigut, S., & Miller, M. A. (1999). Galanin antagonizes vasopressin-stimulated flank marking in male golden hamsters: Brain Research Vol 832(1-2) Jun 1999, 1-6.
• Ferris, C. F., Delville, Y., Grzonka, Z., Luber-Narod, J., & et al. (1993). An iodinated vasopressin (V-sub-1) antagonist blocks flank marking and selectively labels neural binding sites in golden hamsters: Physiology & Behavior Vol 54(4) Oct 1993, 737-747.
• Ferris, C. F., Delville, Y., Irvin, R. W., & Potegal, M. (1994). Septo-hypothalamic organization of a stereotyped behavior controlled by vasopressin in golden hamsters: Physiology & Behavior Vol 55(4) Apr 1994, 755-759.
• Ferris, C. F., & et al. (1984). Vasopressin injected into the hypothalamus triggers a stereotypic behavior in golden hamsters: Science Vol 224(4648) May 1984, 521-523.
• Ferris, C. F., Lu, S.-f., Messenger, T., Guillon, C. D., Heindel, N., Miller, M., et al. (2006). Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior: Pharmacology, Biochemistry and Behavior Vol 83(2) Feb 2006, 169-174.